6505--766-26-2-400-0420 -Charleston CMOP B0302 BRIMONIDINE TARTRATE -(VA-26-00039036)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL CMOP OFFICE (36C770)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C77026Q0104
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs (VA), through its Network Contracting Office 15, Consolidated Mail Outpatient Pharmacy (CMOP) Division, has issued a presolicitation notice for the procurement of Brimonidine Tartrate ophthalmic solution in three distinct package sizes. This requirement is intended to support the pharmaceutical needs of the VA CMOP facility located in Ladson, South Carolina (4136 Carolina Commerce Parkway, Ladson, SC 29456). The procurement is classified under Product Service Code 6505 (Drugs and Biologicals) and NAICS Code 325412 (Pharmaceutical Preparation Manufacturing), with the opportunity set aside exclusively for small business concerns.
The scope of this procurement encompasses the supply and timely delivery of the following Brimonidine Tartrate 0.2% ophthalmic solutions:
- 5ml bottles (NDC: 61314-0143-05), quantity: 720 units
- 10ml bottles (NDC: 61314-0143-10), quantity: 7,200 units
- 15ml bottles (NDC: 24208-0411-15), quantity: 4,320 units
All items must be delivered within 10 days after receipt of order (ARO), ensuring the VA’s continued ability to provide essential medications to its patient population. The packaging multiple for each line item is one, indicating that each unit is to be supplied individually.
The intended outcome of this procurement is to secure a reliable source of Brimonidine Tartrate ophthalmic solution, a critical medication for the VA’s outpatient pharmacy operations, thereby supporting the health and well-being of veterans served by the Charleston CMOP.
Key requirements for offerors include:
- Submission of a signed SF1449 solicitation cover page
- A detailed price schedule in Excel format
- A valid, unexpired state wholesale distributor license, demonstrating compliance with the Drug Supply Chain Security Act (DSCSA)
- A completed Buy American Act (BAA) Certificate, including the place of manufacturing
All solicitation responses must be concise and directly address the stated requirements. Offerors are responsible for monitoring SAM.gov for any amendments or changes to the solicitation. Quotations must be submitted electronically via email to Claudine M. Challinor, the designated contracting officer, at [email protected]. The primary point of contact for this procurement is Claudine M. Challinor, who can also be reached at (571) 388-7250.
This opportunity is a small business set-aside, reinforcing the VA’s commitment to supporting small business participation in federal procurement. Only responsible sources that meet the set-aside criteria and all solicitation requirements will be considered.
The procurement is managed by the National CMOP Office (36C770), a federal office within the Department of Veterans Affairs. The anticipated solicitation release date is March 13, 2026, with responses due by March 17, 2026. Contractors interested in this opportunity should ensure their capabilities align with the pharmaceutical manufacturing and distribution requirements outlined, and that all compliance documentation is current and complete.
For further details and updates, contractors should refer to the official notice on SAM.gov (Opportunity ID: 5922947406d94b15b264486f23cd16c5).